Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE GLOBAL DIAGNOSTIC TESTS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 TYPE SEGMENT LIFELINE CURVE
2.8 MARKET END USER COVERAGE GRID
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTAL ANALYSIS
4.2 PORTERS FIVE FORCES
5 GLOBAL DIAGNOSTIC TESTS MARKET: REGULATIONS
5.1 REGULATIONS IN U.S.
5.2 REGULATIONS IN EUROPE
5.3 REGULATTIONS IN AUSTRALIA
5.4 REGULATTIONS IN SOUTH AFRICA
5.5 REGULATIONS IN BRAZIL
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES
6.1.2 RISING NUMBER OF IVD TESTS CONDUCTED ACROSS THE GLOBE
6.1.3 FAVORABLE REIMBURSEMENT POLICIES
6.1.4 IMPROVING DIAGNOSIS SEEKING RATE ACROSS THE GLOBE
6.2 RESTRAINTS
6.2.1 HIGH COST ASSOCIATED WITH DIAGNOSTIC KITS
6.2.2 LACK OF TRAINED LABORATORY PROFESSIONALS
6.3 OPPORTUNITIES
6.3.1 STRATEGIC INITIATIVES BY THE MARKET PLAYERS
6.3.2 EXPANDING BUSINESS THROUGH SUBSIDIARIES
6.3.3 RISING AWARENESS AND GOVERNMENT FUNDING
6.4 CHALLENGES
6.4.1 STRINGENT RULES AND REGULATIONS FOR THE APPROVAL OF DIAGNOSTIC TEST KITS
6.4.2 OPERATIONAL BARRIERS FACED IN CONDUCTING DIAGNOSTIC TESTS
7 GLOBAL DIAGNOSTIC TESTS MARKET, BY TYPE
7.1 OVERVIEW
7.2 ROUTINE TESTS
7.3 SPECIALIZED TESTS
8 GLOBAL DIAGNOSTIC TESTS MARKET, BY COMPONENT
8.1 OVERVIEW
8.2 SERVICES
8.3 PRODUCT
9 GLOBAL DIAGNOSTIC TESTS MARKET, BY TECHNOLOGY
9.1 OVERVIEW
9.2 IMMUNOASSAY-BASED
9.3 PCR BASED
9.4 NEXT GEN SEQUENCING
9.5 CANNULA
9.6 CHROMATOGRAPHY BASED
9.7 MICROFLUIDICS
9.8 OTHERS
10 GLOBAL DIAGNOSTIC TESTS MARKET, BY MODE OF TESTING
10.1 OVERVIEW
10.2 PRESCRIPTION-BASED TESTING
10.3 OTC TESTING
11 GLOBAL DIAGNOSTIC TESTS MARKET, BY APPLICATION
11.1 OVERVIEW
11.2 ONCOLOGY
11.3 CARDIOLOGY
11.4 ORTHOPEDICS
11.5 GASTROENTROLOGY
11.6 GYNECOLOGY
11.7 NEUROLOGY
11.8 ODONTOLOGY
11.9 OTHERS
12 GLOBAL DIAGNOSTIC TESTS MARKET, BY SAMPLE TYPE
12.1 OVERVIEW
12.2 BLOOD
12.3 URINE
12.4 SALIVA
12.5 SWEAT
12.6 HAIR
12.7 OTHERS
13 GLOBAL DIAGNOSTIC TESTS MARKET, BY TESTING SITE
13.1 OVERVIEW
13.2 LABORATORY BASED TESTING
13.3 AT HOME TESTING
14 GLOBAL DIAGNOSTIC TESTS MARKET, BY TESTING TYPE
14.1 OVERVIEW
14.2 BIOCHEMISTRY
14.3 HEMATOLOGY
14.4 MICROBIOLOGY
14.5 HISTOPATHOLOGY
14.6 OTHERS
15 GLOBAL DIAGNOSTIC TESTS MARKET, BY AGE
15.1 OVERVIEW
15.2 GERIATRIC
15.3 ADULT
15.4 PEDIATRIC
16 GLOBAL DIAGNOSTIC TESTS MARKET, BY END USER
16.1 OVERVIEW
16.2 HOSPITALS
16.3 DIAGNOSTIC CENTER
16.4 AMBULATORY SURGICAL CENTERS (ASCS)
16.5 SPECIALTY CLINICS
16.6 HOME CARE
16.7 BLOOD BANKS
16.8 RESEARCH LABS AND INSTITUTES
16.9 OTHERS
17 GLOBAL DIAGNOSTIC TESTS MARKET, BY DISTRIBUTION CHANNEL
17.1 OVERVIEW
17.2 DIRECT TENDERS
17.3 RETAIL SALES
17.4 ONLINE SALES
18 GLOBAL DIAGNOSTIC TESTS MARKET, BY REGION
18.1 OVERVIEW
18.2 NORTH AMERICA
18.2.1 U.S.
18.2.2 CANADA
18.2.3 MEXICO
18.3 EUROPE
18.3.1 GERMANY
18.3.2 U.K.
18.3.3 FRANCE
18.3.4 ITALY
18.3.5 SPAIN
18.3.6 RUSSIA
18.3.7 POLAND
18.3.8 TURKEY
18.3.9 NETHERLANDS
18.3.10 SWITZERLAND
18.3.11 NORWAY
18.3.12 HUNGARY
18.3.13 AUSTRIA
18.3.14 LITHUANIA
18.3.15 IRELAND
18.3.16 REST OF EUROPE
18.4 ASIA-PACIFIC
18.4.1 CHINA
18.4.2 JAPAN
18.4.3 INDIA
18.4.4 SOUTH KOREA
18.4.5 AUSTRALIA
18.4.6 MALAYSIA
18.4.7 SINGAPORE
18.4.8 THAILAND
18.4.9 INDONESIA
18.4.10 PHILIPPINES
18.4.11 VIETNAM
18.4.12 REST OF ASIA-PACIFIC
18.5 SOUTH AMERICA
18.5.1 BRAZIL
18.5.2 ARGENTINA
18.5.3 PERU
18.5.4 COLOMBIA
18.5.5 VENEZUELA
18.5.6 REST OF SOUTH AMERICA
18.6 MIDDLE EAST AND AFRICA
18.6.1 SOUTH AFRICA
18.6.2 SAUDI ARABIA
18.6.3 U.A.E.
18.6.4 EGYPT
18.6.5 ISRAEL
18.6.6 KUWAIT
18.6.7 REST OF MIDDLE EAST AND AFRICA
19 GLOBAL DIAGNOSTIC TESTS MARKET, COMPANY LANDSCAPE
19.1 COMPANY SHARE ANALYSIS: GLOBAL
19.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
19.3 COMPANY SHARE ANALYSIS: EUROPE
19.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
20 COMPANY PROFILE
20.1 F. HOFFMANN-LA ROCHE LTD.
20.1.1 COMPANY SNAPSHOT
20.1.2 REVENUE ANALYSIS
20.1.3 COMPANY SHARE ANALYSIS
20.1.4 PRODUCT PORTFOLIO
20.1.5 RECENT DEVELOPMENTS
20.2 ABBOTT
20.2.1 COMPANY SNAPSHOT
20.2.2 REVENUE ANALYSIS
20.2.3 COMPANY SHARE ANALYSIS
20.2.4 PRODUCT PORTFOLIO
20.2.5 RECENT DEVELOPMENTS
20.3 DANAHER
20.3.1 COMPANY SNAPSHOT
20.3.2 REVENUE ANALYSIS
20.3.3 COMPANY SHARE ANALYSIS
20.3.4 PRODUCT PORTFOLIO
20.3.5 RECENT DEVELOPMENTS
20.4 SIEMENS HEALTHCARE GMBH
20.4.1 COMPANY SNAPSHOT
20.4.2 REVENUE ANALYSIS
20.4.3 COMPANY SHARE ANALYSIS
20.4.4 PRODUCT PORTFOLIO
20.4.5 RECENT DEVELOPMENTS
20.5 BD
20.5.1 COMPANY SNAPSHOT
20.5.2 REVENUE ANALYSIS
20.5.3 COMPANY SHARE ANALYSIS
20.5.4 PRODUCT PORTFOLIO
20.5.5 RECENT DEVELOPMENTS
20.6 ACON LABORATORIES INC.
20.6.1 COMPANY SNAPSHOT
20.6.2 PRODUCT PORTFOLIO
20.6.3 RECENT DEVELOPMENTS
20.7 BIO-RAD LABORATORIES, INC.
20.7.1 COMPANY SNAPSHOT
20.7.2 REVENUE ANALYSIS
20.7.3 PRODUCT PORTFOLIO
20.7.4 RECENT DEVELOPMENTS
20.8 BIOMEDOMICS INC.
20.8.1 COMPANY SNAPSHOT
20.8.2 PRODUCT PORTFOLIO
20.8.3 RECENT DEVELOPMENTS
20.9 EKF DIAGNOSTICS
20.9.1 COMPANY SNAPSHOT
20.9.2 REVENUE ANALYSIS
20.9.3 PRODUCT PORTFOLIO
20.9.4 RECENT DEVELOPMENTS
20.1 THERMOFISHER
20.10.1 COMPANY SNAPSHOT
20.10.2 REVENUE ANALYSIS
20.10.3 PRODUCT PORTFOLIO
20.10.4 RECENT DEVELOPMENTS
21 QUESTIONNAIRE
22 RELATED REPORTS
List of Table
TABLE 1 INDICATIVE REIMBURSEMENT FOR IN VITRO DIAGNOSTIC TESTS – U.S.
TABLE 2 COST OF DIAGNOSTICS
TABLE 3 THERMO FISHER SCIENTIFIC INC.,
TABLE 4 DANAHER CORPORATION,
TABLE 5 ABBOTT,
TABLE 6 DIFFERENT ASSOCIATIONS FOR DIAGNOSTICS
TABLE 7 GLOBAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 8 GLOBAL ROUTINE TEST IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 9 GLOBAL ROUTINE TESTS IN DIAGNOSTIC TESTS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 10 GLOBAL SPECIALIZED TESTS IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 11 GLOBAL SPECIALIZED TESTS IN DIAGNOSTIC TESTS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 12 GLOBAL DIAGNOSTIC TESTS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 13 GLOBAL SERVICES IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 14 GLOBAL PRODUCT IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 15 GLOBAL DIAGNOSTIC TESTS MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)
TABLE 16 GLOBAL IMMUNOASSAY-BASED IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 17 GLOBAL PCR-BASED IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 18 GLOBAL NEXT GENE SEQUENCING IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 19 GLOBAL SPECTROSCOPY-BASED IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 20 GLOBAL CHROMATOGRAPHY-BASED IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 21 GLOBAL MICROFLUIDICS IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 22 GLOBAL OTHERS IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 23 GLOBAL DIAGNOSTIC TESTS MARKET, BY MODE OF TESTING, 2022-2031 (USD THOUSAND)
TABLE 24 GLOBAL PRESCRIPTION-BASED TESTING IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 25 GLOBAL OTC TESTING IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 26 GLOBAL DIAGNOSTIC TESTS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 27 GLOBAL ONCOLOGY IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 28 GLOBAL CARDIOLOGY IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 29 GLOBAL ORTHOPEDICS IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 30 GLOBAL GASTROENTROLOGY IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 31 GLOBAL GYNECOLOGY IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 32 GLOBAL NEUROLOGY IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 33 GLOBAL ODONTOLOGY IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 34 GLOBAL OTHERS IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 35 GLOBAL DIAGNOSTIC TESTS MARKET, BY SAMPLE TYPE, 2022-2031 (USD THOUSAND)
TABLE 36 GLOBAL BLOOD IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 37 GLOBAL URINE IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 38 GLOBAL SALIVA IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 39 GLOBAL SWEAT IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 40 GLOBAL HAIR IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 41 GLOBAL OTHERS IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 42 GLOBAL DIAGNOSTIC TESTS MARKET, BY TESTING SITE, 2022-2031 (USD THOUSAND)
TABLE 43 GLOBAL LABORATORY BASED TESTING IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 44 GLOBAL AT HOME TESTING IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 45 GLOBAL DIAGNOSTIC TESTS MARKET, BY TESTING TYPE, 2022-2031 (USD THOUSAND)
TABLE 46 GLOBAL BIOCHEMISTRY IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 47 GLOBAL HEMATOLOGY IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 48 GLOBAL MICROBIOLOGY IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 49 GLOBAL HISTOPATHOLOGY IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 50 GLOBAL OTHERS IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 51 GLOBAL DIAGNOSTIC TESTS MARKET, BY AGE, 2022-2031 (USD THOUSAND)
TABLE 52 GLOBAL GERIATRIC IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 53 GLOBAL ADULT IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 54 GLOBAL PEDIATRIC IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 55 GLOBAL DIAGNOSTIC TESTS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 56 GLOBAL HOSPITALS IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 57 GLOBAL DIAGNOSTIC CENTER IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 58 GLOBAL AMBULATORY SURGICAL CENTERS (ASCS) IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 59 GLOBAL SPECIALTY CLINICS IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 60 GLOBAL HOME CARE IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 61 GLOBAL BLOOD BANKS IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 62 GLOBAL RESEARCH LABS AND INSTITUTES IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 63 GLOBAL OTHERS IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 64 GLOBAL DIAGNOSTIC TESTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 65 GLOBAL DIRECT TENDERS IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 66 GLOBAL RETAIL SALES IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 67 GLOBAL ONLINE SALES IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 68 GLOBAL DIAGNOSTIC TESTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
List of Figure
FIGURE 1 GLOBAL DIAGNOSTIC TESTS MARKET: SEGMENTATION
FIGURE 2 GLOBAL DIAGNOSTIC TESTS MARKET: DATA TRIANGULATION
FIGURE 3 GLOBAL DIAGNOSTIC TESTS MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL DIAGNOSTIC TESTS MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 GLOBAL DIAGNOSTIC TESTS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL DIAGNOSTIC TESTS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 GLOBAL DIAGNOSTIC TESTS MARKET: MARKET END USER COVERAGE GRID
FIGURE 8 GLOBAL DIAGNOSTIC TESTS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 GLOBAL DIAGNOSTIC TESTS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 GLOBAL DIAGNOSTIC TESTS MARKET: SEGMENTATION
FIGURE 11 INCREASING PREVALENCE OF CHRONIC DISEASES IS EXPECTED TO DRIVE THE GROWTH OF THE GLOBAL DIAGNOSTIC TESTS MARKET FROM 2024 TO 2031
FIGURE 12 ROUTINE TESTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL DIAGNOSTIC TESTS MARKET IN 2024 TO 2031
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL DIAGNOSTIC TESTS MARKET AND ASIA-APCIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2024 TO 2031
FIGURE 14 ASIA-PACIFIC IS THE FASTEST-GROWING MARKET FOR GLOBAL DIAGNOSTICS TESTS MARKET SERVICE PROVIDERS IN THE FORECAST PERIOD OF 2024 TO 2031
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF GLOBAL DIAGNOSTIC TESTS MARKET
FIGURE 16 GLOBAL DIAGNOSTIC TESTS MARKET: BY TYPE, 2022
FIGURE 17 GLOBAL DIAGNOSTIC TESTS MARKET: BY TYPE, 2024-2031 (USD THOUSAND)
FIGURE 18 GLOBAL DIAGNOSTIC TESTS MARKET: BY TYPE, CAGR (2024-2031)
FIGURE 19 GLOBAL DIAGNOSTIC TESTS MARKET: BY TYPE, LIFELINE CURVE
FIGURE 20 GLOBAL DIAGNOSTIC TESTS MARKET: BY COMPONENT, 2022
FIGURE 21 GLOBAL DIAGNOSTIC TESTS MARKET: BY COMPONENT, 2024-2031 (USD THOUSAND)
FIGURE 22 GLOBAL DIAGNOSTIC TESTS MARKET: BY COMPONENT, CAGR (2024-2031)
FIGURE 23 GLOBAL DIAGNOSTIC TESTS MARKET: BY COMPONENT, LIFELINE CURVE
FIGURE 24 GLOBAL DIAGNOSTIC TESTS MARKET: BY TECHNOLOGY, 2023
FIGURE 25 GLOBAL DIAGNOSTIC TESTS MARKET: BY TECHNOLOGY, 2024-2031 (USD THOUSAND)
FIGURE 26 GLOBAL DIAGNOSTIC TESTS MARKET: BY TECHNOLOGY, CAGR (2024-2031)
FIGURE 27 GLOBAL DIAGNOSTIC TESTS MARKET: BY TECHNOLOGY, LIFELINE CURVE
FIGURE 28 GLOBAL DIAGNOSTIC TESTS MARKET: BY MODE OF TESTING, 2022
FIGURE 29 GLOBAL DIAGNOSTIC TESTS MARKET: BY MODE OF TESTING, 2024-2031 (USD THOUSAND)
FIGURE 30 GLOBAL DIAGNOSTIC TESTS MARKET: BY MODE OF TESTING, CAGR (2024-2031)
FIGURE 31 GLOBAL DIAGNOSTIC TESTS MARKET: BY MODE OF TESTING, LIFELINE CURVE
FIGURE 32 GLOBAL DIAGNOSTIC TESTS MARKET: BY APPLICATION, 2022
FIGURE 33 GLOBAL DIAGNOSTIC TESTS MARKET: BY APPLICATION, 2024-2031 (USD THOUSAND)
FIGURE 34 GLOBAL DIAGNOSTIC TESTS MARKET: BY APPLICATION, CAGR (2024-2031)
FIGURE 35 GLOBAL DIAGNOSTIC TESTS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 36 GLOBAL DIAGNOSTIC TESTS MARKET: BY SAMPLE TYPE, 2022
FIGURE 37 GLOBAL DIAGNOSTIC TESTS MARKET: BY SAMPLE TYPE, 2024-2031 (USD THOUSAND)
FIGURE 38 GLOBAL DIAGNOSTIC TESTS MARKET: BY SAMPLE TYPE, CAGR (2024-2031)
FIGURE 39 GLOBAL DIAGNOSTIC TESTS MARKET: BY SAMPLE TYPE, LIFELINE CURVE
FIGURE 40 GLOBAL DIAGNOSTIC TESTS MARKET: BY TESTING SITE, 2022
FIGURE 41 GLOBAL DIAGNOSTIC TESTS MARKET: BY TESTING SITE, 2024-2031 (USD THOUSAND)
FIGURE 42 GLOBAL DIAGNOSTIC TESTS MARKET: BY TESTING SITE, CAGR (2024-2031)
FIGURE 43 GLOBAL DIAGNOSTIC TESTS MARKET: BY TESTING SITE, LIFELINE CURVE
FIGURE 44 GLOBAL DIAGNOSTIC TESTS MARKET: BY TESTING TYPE, 2022
FIGURE 45 GLOBAL DIAGNOSTIC TESTS MARKET: BY TESTING TYPE, 2024-2031 (USD THOUSAND)
FIGURE 46 GLOBAL DIAGNOSTIC TESTS MARKET: BY TESTING TYPE, CAGR (2024-2031)
FIGURE 47 GLOBAL DIAGNOSTIC TESTS MARKET: BY TESTING TYPE, LIFELINE CURVE
FIGURE 48 GLOBAL DIAGNOSTIC TESTS MARKET: BY AGE, 2022
FIGURE 49 GLOBAL DIAGNOSTIC TESTS MARKET: BY AGE, 2024-2031 (USD THOUSAND)
FIGURE 50 GLOBAL DIAGNOSTIC TESTS MARKET: BY AGE, CAGR (2024-2031)
FIGURE 51 GLOBAL DIAGNOSTIC TESTS MARKET: BY AGE, LIFELINE CURVE
FIGURE 52 GLOBAL DIAGNOSTIC TESTS MARKET: BY END USER, 2023
FIGURE 53 GLOBAL DIAGNOSTIC TESTS MARKET: BY END USER, 2024-2031 (USD THOUSAND)
FIGURE 54 GLOBAL DIAGNOSTIC TESTS MARKET: BY END USER, CAGR (2024-2031)
FIGURE 55 GLOBAL DIAGNOSTIC TESTS MARKET: BY END USER, LIFELINE CURVE
FIGURE 56 GLOBAL DIAGNOSTIC TESTS MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 57 GLOBAL DIAGNOSTIC TESTS MARKET: BY DISTRIBUTION CHANNEL, 2024-2031 (USD THOUSAND)
FIGURE 58 GLOBAL DIAGNOSTIC TESTS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2031)
FIGURE 59 GLOBAL DIAGNOSTIC TESTS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 60 GLOBAL DIAGNOSTIC TESTS MARKET: SNAPSHOT (2023)
FIGURE 61 GLOBAL DIAGNOSTIC TESTS MARKET: COMPANY SHARE 2022 (%)
FIGURE 62 NORTH AMERICA DIAGNOSTIC TESTS MARKET: COMPANY SHARE 2022 (%)
FIGURE 63 EUROPE DIAGNOSTIC TESTS MARKET: COMPANY SHARE 2023 (%)
FIGURE 64 ASIA-PACIFIC DIAGNOSTIC TESTS MARKET: COMPANY SHARE 2023 (%)
